Ken Griffin Medtronic PLC Transaction History

Citadel Advisors LLC

$509 Billion
Q1 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Medtronic PLC stock. As of the latest transaction made, Citadel Advisors LLC holds 1,048,900 shares of MDT stock, worth $84.3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,048,900

Previous 1,672,300 37.28%

Holding current value

$84.3 Million

Previous $138 Million 33.65%

% of portfolio

0.02%

Previous 0.03%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$82.84 - $88.09 $58 Million - $61.7 Million	700,512 Added 1265.26%	755,877 $65.9 Million
Q4 2023 Feb 14, 2024	SELL	$69.43 - $83.43 $30 Million - $36 Million	-432,058 Reduced 88.64%	55,365 $4.56 Million
Q3 2023 Nov 14, 2023	SELL	$78.22 - $90.4 $74.1 Million - $85.7 Million	-947,547 Reduced 66.03%	487,423 $38.2 Million
Q2 2023 Aug 14, 2023	BUY	$79.47 - $91.38 $79 Million - $90.8 Million	993,802 Added 225.27%	1,434,970 $126 Million
Q1 2023 May 15, 2023	SELL	$76.72 - $87.58 $17.4 Million - $19.9 Million	-227,321 Reduced 34.01%	441,168 $35.6 Million

Q4 2022 Feb 14, 2023	BUY	$76.18 - $87.74 $15.3 Million - $17.6 Million	200,726 Added 42.91%	668,489 $52 Million
Q3 2022 Nov 14, 2022	SELL	$80.75 - $95.31 $9.07 Million - $10.7 Million	-112,277 Reduced 19.36%	467,763 $37.8 Million
Q2 2022 Aug 15, 2022	BUY	$87.4 - $113.09 $39.8 Million - $51.6 Million	455,868 Added 367.13%	580,040 $52.1 Million
Q1 2022 May 16, 2022	SELL	$100.58 - $112.38 $48.7 Million - $54.4 Million	-484,289 Reduced 79.59%	124,172 $13.8 Million
Q4 2021 Feb 14, 2022	BUY	$99.53 - $127.75 $40.2 Million - $51.6 Million	403,920 Added 197.48%	608,461 $62.9 Million
Q3 2021 Nov 15, 2021	BUY	$122.75 - $135.17 $6.42 Million - $7.07 Million	52,296 Added 34.35%	204,541 $25.6 Million
Q2 2021 Aug 16, 2021	SELL	$118.19 - $131.5 $331 Million - $369 Million	-2,802,561 Reduced 94.85%	152,245 $18.9 Million
Q1 2021 May 17, 2021	BUY	$111.18 - $119.74 $14.8 Million - $16 Million	133,403 Added 4.73%	2,954,806 $349 Million
Q4 2020 Feb 16, 2021	BUY	$100.57 - $117.14 $5.45 Million - $6.35 Million	54,225 Added 1.96%	2,821,403 $330 Million
Q3 2020 Nov 16, 2020	SELL	$90.13 - $108.78 $2.99 Million - $3.61 Million	-33,169 Reduced 1.18%	2,767,178 $288 Million
Q2 2020 Aug 14, 2020	BUY	$84.11 - $103.33 $150 Million - $184 Million	1,781,209 Added 174.78%	2,800,347 $257 Million
Q1 2020 May 15, 2020	SELL	$72.92 - $121.3 $92.4 Million - $154 Million	-1,266,961 Reduced 55.42%	1,019,138 $91.9 Million
Q4 2019 Feb 14, 2020	BUY	$104.49 - $114.54 $203 Million - $223 Million	1,945,474 Added 571.15%	2,286,099 $259 Million
Q3 2019 Nov 14, 2019	SELL	$98.02 - $111.18 $12.9 Million - $14.6 Million	-131,148 Reduced 27.8%	340,625 $37 Million
Q2 2019 Aug 14, 2019	SELL	$84.15 - $99.38 $58 Million - $68.5 Million	-688,981 Reduced 59.36%	471,773 $45.9 Million
Q1 2019 May 15, 2019	SELL	$82.45 - $93.79 $234 Million - $266 Million	-2,836,116 Reduced 70.96%	1,160,754 $0
Q4 2018 Feb 14, 2019	BUY	$85.8 - $99.49 $139 Million - $161 Million	1,619,083 Added 68.09%	3,996,870 $364 Million
Q3 2018 Nov 13, 2018	BUY	$85.91 - $99.17 $168 Million - $194 Million	1,956,640 Added 464.6%	2,377,787 $0
Q2 2018 Aug 10, 2018	BUY	$77.48 - $87.83 $17.2 Million - $19.5 Million	221,982 Added 111.46%	421,147 $0
Q1 2018 May 11, 2018	SELL	$76.55 - $87.26 $23.4 Million - $26.6 Million	-305,191 Reduced 60.51%	199,165 $16 Million
Q4 2017 Feb 09, 2018	SELL	$76.93 - $83.5 $777,839 - $844,268	-10,111 Reduced 1.97%	504,356 $40.7 Million
Q3 2017 Nov 09, 2017	BUY	$77.71 - $84.6 $40 Million - $43.5 Million	514,467	514,467 $40 Million

Others Institutions Holding MDT

# of Institutions

2,234

Shares Held

1.05B

Call Options Held

6.1M

Put Options Held

7.84M

View Full List

About Medtronic plc

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $107B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

More about MDT

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account